Mark Ragosa
Director of Finance/CFO en KINIKSA PHARMACEUTICALS, LTD. .
Fortuna: 370 352 $ al 31/03/2024
Perfil
Mark Ragosa is currently the Chief Financial Officer & Director at Kiniksa Pharmaceuticals Corp.
He also holds the position of Chief Financial Officer & Senior Vice President at Kiniksa Pharmaceuticals Ltd.
Mr. Ragosa previously worked as the Director-Investor Relations at Ironwood Pharmaceuticals, Inc. and as a Vice President in the Equities Division at Goldman Sachs & Co. LLC.
He completed his undergraduate degree at Bowdoin College.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
08/04/2024 | 18 771 ( 0.05% ) | 370 352 $ | 31/03/2024 |
Cargos activos de Mark Ragosa
Empresas | Cargo | Inicio |
---|---|---|
KINIKSA PHARMACEUTICALS, LTD. | Director of Finance/CFO | 17/12/2020 |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The private company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Director of Finance/CFO | - |
Antiguos cargos conocidos de Mark Ragosa.
Empresas | Cargo | Fin |
---|---|---|
IRONWOOD PHARMACEUTICALS, INC. | Investor Relations Contact | 01/05/2018 |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Corporate Officer/Principal | - |
Formación de Mark Ragosa.
Bowdoin College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
Empresas privadas | 2 |
---|---|
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The private company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Ragosa